Published in Curr Opin Microbiol on January 06, 2006
Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev (2013) 1.21
Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles. Int J Med Microbiol (2013) 0.89
Complete Genome Sequence of Type Strain Pasteurella multocida subsp. multocida ATCC 43137. Genome Announc (2014) 0.75
Genome wide host gene expression analysis in mice experimentally infected with Pasteurella multocida. PLoS One (2017) 0.75
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother (2010) 3.03
Leptospirosis in the Asia Pacific region. BMC Infect Dis (2009) 2.80
Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci U S A (2006) 2.71
Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One (2008) 2.35
The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol Rev (2009) 1.98
Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol (2010) 1.95
Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiol Lett (2006) 1.92
Surfaceome of Leptospira spp. Infect Immun (2005) 1.90
Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun (2002) 1.89
Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev (2004) 1.87
Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays. Infect Immun (2006) 1.52
Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Autophagy (2008) 1.46
Genomic scale analysis of Pasteurella multocida gene expression during growth within the natural chicken host. Infect Immun (2002) 1.46
LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun (2003) 1.44
A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem (2004) 1.44
Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect Immun (2007) 1.42
LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect Immun (2008) 1.42
Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother (2011) 1.41
Genome-wide transposon mutagenesis in pathogenic Leptospira species. Infect Immun (2008) 1.41
Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine. Antimicrob Agents Chemother (2011) 1.41
The Burkholderia pseudomallei type III secretion system and BopA are required for evasion of LC3-associated phagocytosis. PLoS One (2011) 1.38
Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun (2008) 1.35
Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.35
Strategies for Intracellular Survival of Burkholderia pseudomallei. Front Microbiol (2011) 1.35
Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus. Nat Biotechnol (2007) 1.25
Outer membrane proteins of Pasteurella multocida. Vet Microbiol (2010) 1.20
Leptospira interrogans requires a functional heme oxygenase to scavenge iron from hemoglobin. Microbes Infect (2008) 1.20
Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J Antimicrob Chemother (2010) 1.15
Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes Infect (2008) 1.12
A heptosyltransferase mutant of Pasteurella multocida produces a truncated lipopolysaccharide structure and is attenuated in virulence. Infect Immun (2004) 1.10
Signature-tagged mutagenesis of Pasteurella multocida identifies mutants displaying differential virulence characteristics in mice and chickens. Infect Immun (2003) 1.09
Decoration of Pasteurella multocida lipopolysaccharide with phosphocholine is important for virulence. J Bacteriol (2007) 1.09
The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells. PLoS One (2009) 1.09
Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiol (2010) 1.08
Comparative transcriptional and translational analysis of leptospiral outer membrane protein expression in response to temperature. PLoS Negl Trop Dis (2009) 1.08
Transcriptional response of Leptospira interrogans to iron limitation and characterization of a PerR homolog. Infect Immun (2010) 1.05
FlaA proteins in Leptospira interrogans are essential for motility and virulence but are not required for formation of the flagellum sheath. Infect Immun (2012) 1.05
Mutations affecting Leptospira interrogans lipopolysaccharide attenuate virulence. Mol Microbiol (2010) 1.04
Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors. PLoS Pathog (2010) 1.03
Molecular epidemiology of the SRL pathogenicity island. Antimicrob Agents Chemother (2003) 1.03
Pasteurella multocida expresses two lipopolysaccharide glycoforms simultaneously, but only a single form is required for virulence: identification of two acceptor-specific heptosyl I transferases. Infect Immun (2007) 1.01
Regulated site-specific recombination of the she pathogenicity island of Shigella flexneri. Mol Microbiol (2004) 1.01
Crystal structure of LipL32, the most abundant surface protein of pathogenic Leptospira spp. J Mol Biol (2009) 1.00
Genomic-scale analysis of bacterial gene and protein expression in the host. Emerg Infect Dis (2004) 1.00
Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence. Infect Immun (2009) 0.98
A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidis. Microbes Infect (2006) 0.97
Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid (2003) 0.97
Leptospira interrogans catalase is required for resistance to H2O2 and for virulence. Infect Immun (2012) 0.97
Identification of a DNA-damage-inducible regulon in Acinetobacter baumannii. J Bacteriol (2013) 0.97
The fimbrial protein FlfA from Gallibacterium anatis is a virulence factor and vaccine candidate. Infect Immun (2013) 0.96
Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37. Infect Immun (2012) 0.95
Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine (2011) 0.95
Identification of novel immunogens in Pasteurella multocida. Microb Cell Fact (2007) 0.94
Analysis of the Pasteurella multocida outer membrane sub-proteome and its response to the in vivo environment of the natural host. Proteomics (2006) 0.94
Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin. Infect Immun (2007) 0.93
Pasteurella multocida lipopolysaccharide: the long and the short of it. Vet Microbiol (2011) 0.92
Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis. Infect Immun (2005) 0.92
Role of Acinetobacter baumannii UmuD homologs in antibiotic resistance acquired through DNA damage-induced mutagenesis. Antimicrob Agents Chemother (2013) 0.91
The key surface components of Pasteurella multocida: capsule and lipopolysaccharide. Curr Top Microbiol Immunol (2012) 0.90
PorA protein of Campylobacter jejuni is not a cytotoxin mediating inflammatory diarrhoea. Microbes Infect (2005) 0.90
The Leptospira interrogans lexA gene is not autoregulated. J Bacteriol (2005) 0.89
Role for the Burkholderia pseudomallei type three secretion system cluster 1 bpscN gene in virulence. Infect Immun (2011) 0.89
Genomic-scale analysis of Pasteurella multocida gene expression during growth within liver tissue of chickens with fowl cholera. Microbes Infect (2004) 0.88
Beclin 1 is required for starvation-enhanced, but not rapamycin-enhanced, LC3-associated phagocytosis of Burkholderia pseudomallei in RAW 264.7 cells. Infect Immun (2012) 0.87
Use of a high-throughput screen to identify Leptospira mutants unable to colonize the carrier host or cause disease in the acute model of infection. J Med Microbiol (2013) 0.87
Excision of the Shigella resistance locus pathogenicity island in Shigella flexneri is stimulated by a member of a new subgroup of recombination directionality factors. J Bacteriol (2004) 0.86
Structural and genetic basis for the serological differentiation of Pasteurella multocida Heddleston serotypes 2 and 5. J Bacteriol (2009) 0.86
Role of attP in integrase-mediated integration of the Shigella resistance locus pathogenicity island of Shigella flexneri. Antimicrob Agents Chemother (2004) 0.86
Characterization of a locus encoding four paralogous outer membrane lipoproteins of Brachyspira hyodysenteriae. Microbes Infect (2003) 0.85
Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J Infect Dis (2011) 0.85
Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE. PLoS One (2012) 0.84
High-temperature protein G is an essential virulence factor of Leptospira interrogans. Infect Immun (2013) 0.83
Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation. Vaccine (2012) 0.83
Functional characterization of HgbB, a new hemoglobin binding protein of Pasteurella multocida. Microb Pathog (2003) 0.83
Pasteurella multocida Heddleston serovars 1 and 14 express different lipopolysaccharide structures but share the same lipopolysaccharide biosynthesis outer core locus. Vet Microbiol (2011) 0.83
Leptospiral outer membrane protein LipL41 is not essential for acute leptospirosis but requires a small chaperone protein, lep, for stable expression. Infect Immun (2013) 0.83
Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin. Clin Vaccine Immunol (2008) 0.83
Characterization of the lipopolysaccharide from Pasteurella multocida Heddleston serovar 9: identification of a proposed bi-functional dTDP-3-acetamido-3,6-dideoxy-α-D-glucose biosynthesis enzyme. Glycobiology (2011) 0.82
Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy. Int J Antimicrob Agents (2011) 0.82
Leptospiral outer membrane protein LMB216 is involved in enhancement of phagocytic uptake by macrophages. Cell Microbiol (2014) 0.82
Evolutionary analysis of Burkholderia pseudomallei identifies putative novel virulence genes, including a microbial regulator of host cell autophagy. J Bacteriol (2013) 0.81
Use of luminescent Leptospira interrogans for enumeration in biological assays. J Clin Microbiol (2010) 0.81
Pasteurella multocida Heddleston serovar 3 and 4 strains share a common lipopolysaccharide biosynthesis locus but display both inter- and intrastrain lipopolysaccharide heterogeneity. J Bacteriol (2013) 0.80
Structure and biosynthetic locus of the lipopolysaccharide outer core produced by Pasteurella multocida serovars 8 and 13 and the identification of a novel phospho-glycero moiety. Glycobiology (2012) 0.80
Differential expression of the Bhmp39 major outer membrane proteins of Brachyspira hyodysenteriae. Infect Immun (2006) 0.79
Leptospiral LruA is required for virulence and modulates an interaction with mammalian apolipoprotein AI. Infect Immun (2013) 0.79
Characterization of two lipoproteins in Pasteurella multocida. Microbes Infect (2004) 0.78
Characterization of TolC efflux pump proteins from Pasteurella multocida. Antimicrob Agents Chemother (2008) 0.78
Proposed revisions to the nomenclature for Brachyspira membrane proteins and lipoproteins. Microbiology (2006) 0.78
The Pasteurella multocida nrfE gene is upregulated during infection and is essential for nitrite reduction but not for virulence. J Bacteriol (2005) 0.78
Natural selection in the chicken host identifies 3-deoxy-D-manno-octulosonic acid kinase residues essential for phosphorylation of Pasteurella multocida lipopolysaccharide. Infect Immun (2010) 0.77
Vaccination against fowl cholera with acapsular Pasteurella multocida A:1. Vaccine (2005) 0.77
The major surface Vsp proteins of Brachyspira hyodysenteriae form antigenic protein complexes. Vet Microbiol (2010) 0.77
Precipitation of iron on the surface of Leptospira interrogans is associated with mutation of the stress response metalloprotease HtpX. Appl Environ Microbiol (2013) 0.77
Leptospirosis in horses. Vet Microbiol (2013) 0.77
Characterization of a lipopolysaccharide mutant of Leptospira derived by growth in the presence of an anti-lipopolysaccharide monoclonal antibody. FEMS Microbiol Lett (2010) 0.76
Membrane proteins of Pseudoalteromonas tunicata during the transition from planktonic to extracellular matrix-adherent state. Environ Microbiol Rep (2011) 0.76
Application of protein purification methods for the enrichment of a cytotoxin from Campylobacter jejuni. BMC Microbiol (2012) 0.75
Structural and functional characterization of an orphan ATP-binding cassette ATPase involved in manganese utilization and tolerance in Leptospira spp. J Bacteriol (2013) 0.75
The Central Massachusetts Oral Health Initiative (CMOHI): a successful public-private community health collaboration. J Public Health Dent (2010) 0.75